Clinical Trial: A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07318805) titled 'A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors' on Dec. 04, 2025.

Brief Summary: The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-cancer therapy is a type of treatment to stop the growth of cancer. This study also aims to find the best amount of study medication.

This study is seeking participants that have advanced or metastatic breast cancer (BC), or advanced or metastatic colorectal cancer (CRC).

All participants in this study will take the study medication (...